Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02453685
What this trial is testing

Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 335
Large-scale testing (Phase 3)Study completedNCT01009580
What this trial is testing

Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 447
Early research (Phase 1)Study completedNCT01399346
What this trial is testing

Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Medical University of Graz 12
Post-approval studies (Phase 4)Study completedNCT00619697
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 260
Testing effectiveness (Phase 2)Study completedNCT00842361
What this trial is testing

Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 66
Large-scale testing (Phase 3)Study completedNCT01527539
What this trial is testing

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 25
Not applicableStudy completedNCT00771680
What this trial is testing

Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 10,408
Early research (Phase 1)Study completedNCT03407599
What this trial is testing

A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 46
Post-approval studies (Phase 4)Study completedNCT00597233
What this trial is testing

Human Insulin NPH and Insulin Aspart in Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 91
Large-scale testing (Phase 3)Study completedNCT00313001
What this trial is testing

Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 373
Post-approval studies (Phase 4)Study completedNCT00998335
What this trial is testing

Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Florida 30
Not applicableStudy completedNCT03579615
What this trial is testing

Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart

Who this might be right for
Diabetes Mellitus, Type 1
Manchester University NHS Foundation Trust 18
Large-scale testing (Phase 3)Study completedNCT01474538
What this trial is testing

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 122
Large-scale testing (Phase 3)Study completedNCT00097071
What this trial is testing

Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 299
Large-scale testing (Phase 3)Study completedNCT00504673
What this trial is testing

Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 277
Large-scale testing (Phase 3)Study completedNCT02100475
What this trial is testing

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 31
Early research (Phase 1)Study completedNCT01487811
What this trial is testing

Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 50
Early research (Phase 1)Study completedNCT01269606
What this trial is testing

Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 13
Large-scale testing (Phase 3)Study completedNCT01388361
What this trial is testing

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 413
Large-scale testing (Phase 3)Study completedNCT01680341
What this trial is testing

Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 272
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation